Search for: "Apotex, Inc. " Results 41 - 60 of 674
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Nov 2021, 5:21 pm by Unknown
Department of Justice press release states, in part: Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
5 Nov 2021, 5:21 pm by Unknown
Department of Justice press release states, in part: Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
6 Oct 2021, 10:12 am by Peter Briccetti
Generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, will pay $447.2 million to settle allegations that they conspired to artificially inflate the price of multiple generic drugs. [read post]
1 Oct 2021, 9:28 am by jeffreynewmanadmin
Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
29 Dec 2020, 9:15 am by Theodore Rand
Apotex, Inc., decided last week, the Federal Circuit affirmed a district court finding of infringement under the doctrine of equivalents. [read post]
29 Dec 2020, 9:15 am by Theodore Rand
Apotex, Inc., decided last week, the Federal Circuit affirmed a district court finding of infringement under the doctrine of equivalents. [read post]
27 Dec 2020, 9:59 pm by Patent Docs
Hospira, Inc., directed to the same patent and with assertion of infringement under the... [read post]
21 Dec 2020, 2:56 pm by Lawrence B. Ebert
The outcome: Apotex, Inc. appeals from the judgment of the district court in a patent-infringement suit brought by Eli Lilly & Company under the Hatch-Waxman Act, 21 U.S.C. [read post]
11 Nov 2020, 4:14 pm by Bona Law PC
Author: Luis Blanquez If you read our articles regularly, you know an antitrust compliance policy is a strong tool to educate directors and employees to avoid risks of anticompetitive conduct. [read post]
Apotex Inc., the defendants converted their Paragraph IV certifications for certain patents at issue to Paragraph III certifications. [read post]
17 May 2020, 2:57 am by Anastasiia Kyrylenko
Public.Resource.Org, Inc. | [GuestPost] The Nadorcott Case - Shifting the plant variety paradigm from a proprietary to a liability rule | In memoriam: Dr. [read post]
11 May 2020, 3:59 am by Deb Givens
  Drugmaker AbbVie Inc. has won U.S. antitrust approval to buy Botox maker Allergan, a blockbuster $63 billion deal when it was announced last year, the companies said on Tuesday. [read post]
24 Apr 2020, 5:24 am by Lawrence B. Ebert
On April 23, 2020, the CAFC decided a case related to Gilenya, which related to the issue of standing of the company Argentum to challenge US 9,187,405 in IPR proceedings.On February 3, 2017, Apotex Inc. and Apotex Corp. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]